CN104013901A - Medicament for treating pelvic inflammation - Google Patents
Medicament for treating pelvic inflammation Download PDFInfo
- Publication number
- CN104013901A CN104013901A CN201410296689.7A CN201410296689A CN104013901A CN 104013901 A CN104013901 A CN 104013901A CN 201410296689 A CN201410296689 A CN 201410296689A CN 104013901 A CN104013901 A CN 104013901A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- herba
- fructus
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating pelvic inflammation. The medicament is prepared from the following traditional Chinese medicinal materials in parts by weight: 16-32 parts of tree peony bark, 10-20 parts of schisandra fruit, 5-15 parts of gynostemma pentaphyllum, 5-15 parts of bilberry, 5-15 parts of tamarind, 5-15 parts of sandwort, 3-9 parts of black sesame seed, 3-9 parts of lawn pennywort herb, 3-9 parts of fritillary bulb, 3-9 parts of shelled cedar seed, 1-3 parts of asiatic centella, 1-3 parts of ginkgo leaf, 1-3 parts of Chinese scholar tree fruit, 1-3 parts of ilex latifolia, 1-3 parts of purslane, 1-3 parts of turtleback, 1-3 parts of eupatorium, 1-3 parts of arborvitae leaf, 1-3 parts of epimedium, 1-3 parts of white cardamom and 1-3 parts of medlar. The medicament has the beneficial effects that the medicament has the advantages of good treatment effect, short treatment course, small side effect, convenience in use and the like on pelvic inflammation.
Description
Technical field
The present invention relates to technical field of Chinese medicines, specifically refer to a kind of medicament for the treatment of pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease is the common disease of women, is also a kind of disease that is relatively difficult to radical cure, is mainly in menstrual period, puerperal, artificial abortion's pressed on ring, cuts open that produce in palace or gynecologic surgery, and antibacterial enters traumatic infection and falls ill.Pelvic inflammatory disease refers to the inflammation of women's anogenital and surrounding tissue thereof, mainly contains endometritis, salpingitis, tubo-ovarian abscess, pelvioperitonitis.Inflammation can be confined to a position, also can involve several positions simultaneously.
At present, it is main that treatment primary disease adopts the antibiosis anti-inflammatory drug of doctor trained in Western medicine more, though the state of an illness is temporarily controlled to some extent, but easily recurrence, and the antibiosis anti-inflammatory drug of doctor trained in Western medicine has great harm to the liver of human body, kidney, administration time elder also likely causes other complication, and doctor trained in Western medicine antibiotic medicine exists, and expensive, drug treatment is long, the problem such as produce effects slowly.
Herbal retention enema method in clinical use for many years, is a reasonable route of administration, is mainly the absorption by intestinal wall, can utilize the semi-transparent permeability of the membrane of intestinal wall to be rapidly absorbed, and cause the therapeutical effect of whole body, especially to the organ closing on, as more remarkable in effects such as pelvic cavity, abdominal cavities.And, both can be in the while in hospital by nurse operation, after Ye Keli institute, Self-operating at home.
Summary of the invention
In order to make up the deficiencies in the prior art, the invention provides the medicament of a kind of good effect, short treating period, side effect treatment pelvic inflammatory disease little, easy to use.Specifically be achieved by the following technical solution:
Treat a medicament for pelvic inflammatory disease, by the Chinese crude drug of following weight portion, made: 16 ~ 32 parts of Cortex Moutans, 10 ~ 20 parts of Fructus Schisandrae Chinensis, 5 ~ 15 parts of Herb Gynostemmae Pentaphylli, 5 ~ 15 parts of Pericarpium Citri tangerinaes, 5 ~ 15 parts of Fructus Tamarindi Indicae, 5 ~ 15 parts of sandworts, 3 ~ 9 parts of Semen Sesami Nigrums, 3 ~ 9 parts of Herba Hydrocotyleses, 3 ~ 9 parts of Bulbus Fritillariae Ussuriensiss, 3 ~ 9 parts of Semen Platycladi, 1 ~ 3 part of Herba Centellae, 1 ~ 3 part of Folium Ginkgo, 1 ~ 3 part of Fructus Sophorae, 1 ~ 3 part of Folium Ilicis, 1 ~ 3 part of Herba Portulacae, 1 ~ 3 part of Carapax Et Plastrum Testudinis, 1 ~ 3 part of Herba Eupatorii, 1 ~ 3 part of Cacumen Platycladi, 1 ~ 3 part of Herba Epimedii, 1 ~ 3 part of Fructus Amomi Rotundus, 1 ~ 3 part of Fructus Lycii.
Preferably, treat a medicament for pelvic inflammatory disease, by the Chinese crude drug of following weight portion, made: 24 parts of Cortex Moutans, 15 parts of Fructus Schisandrae Chinensis, 10 parts of Herb Gynostemmae Pentaphylli, 10 parts of Pericarpium Citri tangerinaes, 10 parts of Fructus Tamarindi Indicae, 10 parts of sandworts, 6 parts of Semen Sesami Nigrums, 6 parts of Herba Hydrocotyleses, 6 parts of Bulbus Fritillariae Ussuriensiss, 6 parts of Semen Platycladi, 2 parts of Herba Centellaes, 2 parts of Folium Ginkgos, 2 parts of Fructus Sophorae, 2 parts of Folium Ilicis, 2 parts of Herba Portulacaes, 2 parts of Carapax Et Plastrum Testudiniss, 2 parts of Herba Eupatoriis, 2 parts of Cacumen Platycladis, 2 parts of Herba Epimedii, 2 parts of Fructus Amomi Rotunduss, 2 parts of Fructus Lycii.
The preparation method of the medicament of above-mentioned treatment pelvic inflammatory disease is: the Chinese crude drug that takes described weight portion is put into drug-decocting appliance, adds the clean water that meets drinking water standard, and it is degree that amount of water be take over powder 2-3cm; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
The Therapeutic Method of the medicament for the treatment of pelvic inflammatory disease of the present invention: before sleeping every night, after emptying stool, urine, get right arm reclining, make buttocks shift near edge of bed, by intravenous transfusion methods, connect transfusion device, Exhaust Gas, transfusion device cuts off syringe needle, and end is coated a small amount of lubricating oil, from anus, insert rectum 10 ~ 15cm slowly, medicinal liquid is slowly splashed into.Fluid temperature is advisable with 39 ℃ ~ 41 ℃, and pressure is low, and liquid level must not surpass 30cm apart from anus, after having filled with, lies up as far as possible.Before sleeping every night, coloclysis is 1 time, and each about 50ml 2 weeks is 1 course for the treatment of, and can fully recover general 2 courses for the treatment of.
The medicament for the treatment of pelvic inflammatory disease of the present invention, its beneficial effect is: for pelvic inflammatory disease, have the advantages such as good effect, short treating period, side effect be little, easy to use.
the specific embodiment:
Below in conjunction with embodiment and case, the present invention is further illustrated.
Embodiment 1:
Take Cortex Moutan 16g, Fructus Schisandrae Chinensis 20g, Herb Gynostemmae Pentaphylli 5g, Pericarpium Citri tangerinae 15g, Fructus Tamarindi Indicae 5g, sandwort 15g, Semen Sesami Nigrum 3g, Herba Hydrocotyles 9g, Bulbus Fritillariae Ussuriensis 3g, Semen Platycladi 9g, Herba Centellae 1g, Folium Ginkgo 3g, Fructus Sophorae 1g, Folium Ilicis 3g, Herba Portulacae 1g, Carapax Et Plastrum Testudinis 3g, Herba Eupatorii 1g, Cacumen Platycladi 3g, Herba Epimedii 1g, Fructus Amomi Rotundus 3g, Fructus Lycii 1g puts into drug-decocting appliance, add the clean water that meets drinking water standard, it is degree that amount of water be take over powder 2-3cm; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
Embodiment 2:
Take Cortex Moutan 32g, Fructus Schisandrae Chinensis 10g, Herb Gynostemmae Pentaphylli 15g, Pericarpium Citri tangerinae 5g, Fructus Tamarindi Indicae 15g, sandwort 5g, Semen Sesami Nigrum 9g, Herba Hydrocotyles 3g, Bulbus Fritillariae Ussuriensis 9g, Semen Platycladi 3g, Herba Centellae 3g, Folium Ginkgo 1g, Fructus Sophorae 3g, Folium Ilicis 1g, Herba Portulacae 3g, Carapax Et Plastrum Testudinis 1g, Herba Eupatorii 3g, Cacumen Platycladi 1g, Herba Epimedii 3g, Fructus Amomi Rotundus 1g, Fructus Lycii 3g puts into drug-decocting appliance, add the clean water that meets drinking water standard, it is degree that amount of water be take over powder 2-3cm; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
Embodiment 3:
Take Cortex Moutan 24g, Fructus Schisandrae Chinensis 15g, Herb Gynostemmae Pentaphylli 10g, Pericarpium Citri tangerinae 10g, Fructus Tamarindi Indicae 10g, sandwort 10g, Semen Sesami Nigrum 6g, Herba Hydrocotyles 6g, Bulbus Fritillariae Ussuriensis 6g, Semen Platycladi 6g, Herba Centellae 2g, Folium Ginkgo 2g, Fructus Sophorae 2g, Folium Ilicis 2g, Herba Portulacae 2g, Carapax Et Plastrum Testudinis 2g, Herba Eupatorii 2g, Cacumen Platycladi 2g, Herba Epimedii 2g, Fructus Amomi Rotundus 2g, Fructus Lycii 2g puts into drug-decocting appliance, add the clean water that meets drinking water standard, it is degree that amount of water be take over powder 2-3cm; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
The present invention treats the clinical trial data of pelvic inflammatory disease:
Select Huainan City, Anhui Province Patients with Pelvic Inflammatory Disease 132 examples, 26 ~ 50 years old age, 38 years old mean age.Diagnostic criteria: 1, symptom: the conscious soreness of waist repeatedly, lower abdomen pendant pain, leucorrhoea grow in quantity, there is abnormal flavour, heat occasionally occurs together; 2, gynecologial examination: body of uterus tenderness, bilateral attachment area thickens, and tenderness is obvious; 3, B ultrasonic prompting: pelvic hydrops or inflammatory mass.This 132 routine patient is random, be equally divided into three treatment groups, every group of 44 examples.Wherein, treatment group 1 adopts the pharmaceutical treatment of the embodiment of the present invention 1; Treatment group 2 adopts the pharmaceutical treatment of the embodiment of the present invention 2; Treatment group 3 adopts the pharmaceutical treatment of the embodiment of the present invention 3.
Therapeutic Method: before sleeping every night, after emptying stool, urine, get right arm reclining, make buttocks shift near edge of bed, press intravenous transfusion methods, connect transfusion device, Exhaust Gas, transfusion device cuts off syringe needle, end is coated a small amount of lubricating oil, inserts rectum 10 ~ 15cm slowly from anus, and medicinal liquid is slowly splashed into.Fluid temperature is advisable with 39 ℃ ~ 41 ℃, and pressure is low, and liquid level must not surpass 30cm apart from anus, after having filled with, lies up as far as possible.Before sleeping every night, coloclysis is 1 time, and each about 50ml 2 weeks is 1 course for the treatment of, treats continuously 2 courses for the treatment of.During treatment, ban use of Chinese medicine, Western medicine or other drug and the therapy of other treatment pelvic inflammatory disease.
Efficacy assessment standard:
Recovery from illness: symptom, sign disappear, and gynecologial examination is normal, and ultrasound diagnosis is normal, nothing recurrence in half a year;
Effective: subjective symptoms disappears or obviously alleviates, in gynecological, examine and check that uterus and adnexa tenderness obviously alleviate but still have, or occasionally have recurrence in half a year;
Invalid: clinical symptoms and sign and treatment are front without much changes.
Therapeutic outcome is in Table 1:
Table 1 therapeutic outcome
Conclusion:
In clinical trial process, patient finds no any untoward reaction.Clinical test results shows, medicament of the present invention is used safety, and the total effective rate of pelvic inflammatory disease is reached more than 97.7%, and wherein the medicament of embodiment 3 is best to the curative effect of pelvic inflammatory disease, cure rate is the highest, be the active drug for the treatment of pelvic inflammatory disease, there is well clinical and dissemination.
The above, be only preferred embodiment of the present invention, is not intended to limit protection scope of the present invention.One skilled in the art will appreciate that protection scope of the present invention is as the criterion with appending claims.
Claims (1)
1. a medicament for the treatment of pelvic inflammatory disease, it is characterized in that, by the Chinese crude drug of following weight portion, made: 16 ~ 32 parts of Cortex Moutans, 10 ~ 20 parts of Fructus Schisandrae Chinensis, 5 ~ 15 parts of Herb Gynostemmae Pentaphylli, 5 ~ 15 parts of Pericarpium Citri tangerinaes, 5 ~ 15 parts of Fructus Tamarindi Indicae, 5 ~ 15 parts of sandworts, 3 ~ 9 parts of Semen Sesami Nigrums, 3 ~ 9 parts of Herba Hydrocotyleses, 3 ~ 9 parts of Bulbus Fritillariae Ussuriensiss, 3 ~ 9 parts of Semen Platycladi, 1 ~ 3 part of Herba Centellae, 1 ~ 3 part of Folium Ginkgo, 1 ~ 3 part of Fructus Sophorae, 1 ~ 3 part of Folium Ilicis, 1 ~ 3 part of Herba Portulacae, 1 ~ 3 part of Carapax Et Plastrum Testudinis, 1 ~ 3 part of Herba Eupatorii, 1 ~ 3 part of Cacumen Platycladi, 1 ~ 3 part of Herba Epimedii, 1 ~ 3 part of Fructus Amomi Rotundus, 1 ~ 3 part of Fructus Lycii; Preparation method is: the Chinese crude drug that takes described weight portion is put into drug-decocting appliance, adds the clean water that meets drinking water standard, and it is degree that amount of water be take over powder 2-3cm; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410296689.7A CN104013901A (en) | 2014-06-27 | 2014-06-27 | Medicament for treating pelvic inflammation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410296689.7A CN104013901A (en) | 2014-06-27 | 2014-06-27 | Medicament for treating pelvic inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104013901A true CN104013901A (en) | 2014-09-03 |
Family
ID=51431082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410296689.7A Pending CN104013901A (en) | 2014-06-27 | 2014-06-27 | Medicament for treating pelvic inflammation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104013901A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104922562A (en) * | 2015-06-29 | 2015-09-23 | 孙霞 | Traditional Chinese medicine for treating pelvic inflammation disease |
CN105477252A (en) * | 2016-01-31 | 2016-04-13 | 济南新时代医药科技有限公司 | Traditional Chinese medicine for treating chronic pelvic inflammatory disease |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070298028A1 (en) * | 2004-02-19 | 2007-12-27 | Bayer Healthcare Ag | Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3) |
CN103784662A (en) * | 2014-01-16 | 2014-05-14 | 青岛市城阳区人民医院 | Chinese medicinal herbal preparation for treating pelvic inflammation and preparation method thereof |
-
2014
- 2014-06-27 CN CN201410296689.7A patent/CN104013901A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070298028A1 (en) * | 2004-02-19 | 2007-12-27 | Bayer Healthcare Ag | Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3) |
CN103784662A (en) * | 2014-01-16 | 2014-05-14 | 青岛市城阳区人民医院 | Chinese medicinal herbal preparation for treating pelvic inflammation and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
张立: "妇女更年期综合征的辨证分型与治疗", 《中医药学刊》 * |
许家莹等: "补肾调周法治疗慢性盆腔炎临床研究", 《辽宁中医杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104922562A (en) * | 2015-06-29 | 2015-09-23 | 孙霞 | Traditional Chinese medicine for treating pelvic inflammation disease |
CN105477252A (en) * | 2016-01-31 | 2016-04-13 | 济南新时代医药科技有限公司 | Traditional Chinese medicine for treating chronic pelvic inflammatory disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102743501B (en) | A kind of prescription for the treatment of qi-deficiency type uterine prolapse | |
CN102949569A (en) | Traditional Chinese medicine composition for treating frequent micturition, urgent urination and micturition pain caused by benign prostatic hyperplasia | |
CN103908611A (en) | Traditional Chinese medicine preparation for treating colon cancer and preparation method of traditional Chinese medicine preparation | |
CN103800842A (en) | Traditional Chinese medicine composition for treating carcinoma of urinary bladder | |
CN104013901A (en) | Medicament for treating pelvic inflammation | |
CN103585585B (en) | A kind of Chinese medicine composition for the treatment of choledocholithiasis and preparation method thereof | |
CN102872300B (en) | Traditional Chinese medicine for treating non-gonococcal urethritis | |
CN104857091A (en) | Traditional Chinese medicine composition for treating renal calculus | |
CN104013784A (en) | Medicament for treating pelvic inflammation | |
CN103341059A (en) | Chinese medicine composition for treating non-gonococcal urethritis | |
CN101357199A (en) | Traditional Chinese medicine for treating appendicitis | |
CN104013857A (en) | Medicament for treating pelvic inflammation | |
CN104398985A (en) | Traditional Chinese drug for treating abdominal distension after gynecologic surgery anesthesia | |
CN104042984A (en) | Medicament for treating pelvic inflammation | |
CN103550372B (en) | Medicament for medical abortion | |
CN104013893A (en) | Medicament for treating pelvic inflammation | |
CN103356797A (en) | Chinese medicine composition for treating kidney stone | |
CN103566003B (en) | Pharmaceutical composition for treating cesarean postpartum urinary retention | |
CN103599407B (en) | A kind ofly be used for the treatment of prostatitis and with the Chinese medicine composition of insomnia and dreamful sleep | |
CN104056244A (en) | Traditional Chinese medicine preparation for treating kidney stone | |
CN104013869A (en) | Medicament for treating pelvic inflammation | |
CN105287954A (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type postpartum abdominal pain | |
CN104013727A (en) | Medicament for treating pelvic inflammation | |
CN104056112A (en) | Medicament for treating ulcerative colitis | |
CN104042899A (en) | Medicament for treating ulcerative colitis (UC) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140903 |